E.R.I.C. Cancer Playbook, in partnership with Whole Health Oncology Institute, is unveiling a pioneering initiative to provide affordable access to Full Extract Cannabis Oil (FECO) for cancer patients, available exclusively in Colorado. The FECO Program, developed in collaboration with Native Roots Cannabis Co. and Yeti Farms, aims to merge compassionate access to high-quality cannabis medicine with real-world data collection to inform future cancer care and research.
For the first time, adult cancer patients aged 21 and older worldwide can access FECO through Colorado’s recreational cannabis market without a medical marijuana card. Patients who register for the program will receive FECO at a discounted price, while E.R.I.C. Cancer Playbook collects patient-reported outcomes to evaluate cannabis efficacy in real-world settings—often proving more reflective than traditional FDA clinical trials.
Expanding Research and Real-World Data Collection
Earlier this year, E.R.I.C. Cancer Playbook published the largest meta-analysis on medical cannabis and cancer symptoms, covering over 10,000 studies. Building on this milestone, the organization has expanded its research collaborations, digital infrastructure, and patient network, aiming to transform how real-world data informs cancer care and treatment decisions.
“E.R.I.C. Cancer Playbook FECO Program is a meaningful step forward in supporting cancer patients worldwide,” said Jim Gerencser, Lead Visionary and Co-Founder. “By combining access to high-quality FECO with data that increases patient autonomy, we’re helping people make informed choices about their care. This program also provides hope, encouragement, and a pathway for future patients to benefit from what we’re learning today.”
The program is set to launch October 23, with a goal of serving 100 cancer patients in its first year. The initiative addresses critical access and affordability barriers that have historically limited patient use of cannabis medicine. Initially, patients can visit the Native Roots Santa Fe store in central Denver (2645 S. Santa Fe Drive), with plans to expand to additional locations as demand grows.
Partnerships Supporting Access and Quality
Native Roots Cannabis Co., Colorado’s leading dispensary, will serve as the program’s retail partner.
“Promoting health and wellness has always been a core mission of Native Roots,” said Liz Zukowski, Director of Public Affairs. “We are honored to serve as the Colorado dispensary partner for the FECO Program and expand access for patients who are incorporating cannabis into their cancer treatment plans.”
Yeti Farms, based in Pueblo, Colorado, will oversee cultivation, processing, and compliance, providing its services pro bono to ensure patients receive safe, high-quality FECO.
“Yeti Farms is proud to be a cornerstone partner of E.R.I.C. Cancer Playbook FECO Program in Colorado,” said Shawn Honaker, Founder and Owner. “We are committed to ensuring patients receive safe, high-quality FECO without financial barriers through this groundbreaking program.”
Patient-Centric Enrollment and Support
Patients can register for the Colorado FECO Program through a simple online survey at ericcancerplaybook.org. Enrolled patients gain access to:
- A personalized “Playbook” based on shared patient experiences.
- Connections to supportive clinicians knowledgeable about cannabis medicine.
- Guidance and education on incorporating FECO into their treatment plans.
The program uses a pay-what-you-can model, removing financial obstacles and making FECO more affordable for patients. FECO typically costs $30–$60 per gram, but under the program, it is available at discounted rates exclusively at Native Roots dispensaries.
Integrating Research with Patient Care
The program’s research component, developed in collaboration with leading institutions including:
- Society of Cannabis Clinicians
- Institute of Cannabis Research
- Veterinary Cannabis Society
…supports ongoing peer-reviewed studies exploring how cannabis can help manage cancer symptoms and improve quality of life. By gathering real-world patient-reported outcomes, the initiative contributes valuable data that can complement traditional clinical trials and guide evidence-based care.
“After more than six years of working to help cancer patients in Oklahoma gain access to FECO, I’m proud to see the dream of E.R.I.C. Cancer Playbook FECO Program launching into new markets and expanding our reach worldwide,” said Jamie Bennett, Co-Founder. “This initiative not only helps patients gain access to high-quality FECO, but also supports their entire journey—offering guidance, encouragement, and hope along the way.”
Why FECO Matters for Cancer Patients
Full Extract Cannabis Oil (FECO) is a concentrated cannabis extract that retains the full spectrum of cannabinoids, terpenes, and other bioactive compounds found in the cannabis plant. Patients and clinicians report that FECO may help:
- Manage pain and nausea associated with cancer and chemotherapy.
- Improve appetite and sleep quality.
- Support emotional well-being and overall quality of life.
E.R.I.C. Cancer Playbook’s focus on high-quality, lab-tested FECO ensures patients receive a safe, standardized product, addressing the inconsistency and quality concerns that often accompany cannabis products in other markets.
Building a Global Network of Support
Beyond access and affordability, the program aims to connect cancer patients worldwide, fostering a community of shared knowledge and experience. By collecting patient-reported outcomes, E.R.I.C. Cancer Playbook is developing a living dataset that captures the nuances of FECO’s effects across diverse patient populations. This approach positions the organization as a leader in real-world cannabis research, complementing existing scientific literature and informing future clinical practices.
Vision for the Future
The E.R.I.C. Cancer Playbook FECO Program represents a paradigm shift in how cannabis medicine can be delivered to patients—combining accessibility, affordability, and actionable research. Its unique model demonstrates the potential for compassionate care and evidence generation to coexist, advancing both patient outcomes and scientific understanding.
“This program exemplifies the mission of E.R.I.C. Cancer Playbook: to empower patients, reduce barriers, and generate knowledge that benefits future cancer patients,” said Jim Gerencser. “By expanding access to FECO in Colorado, we’re taking a bold step toward global impact, proving that innovative medicine can be both compassionate and scientifically grounded.”
As the program grows, plans are in place to expand to additional dispensaries in Colorado and potentially other states, increasing availability and ensuring more patients can benefit from high-quality cannabis medicine.
For more information, to register for the FECO Program, or to learn about participation in research studies, visit ericcancerplaybook.org.
The E.R.I.C. Cancer Playbook FECO Program is a landmark initiative that merges patient care, scientific research, and community support—providing cancer patients with a lifeline of hope, access, and data-driven insights to help navigate their journey.
